Skip to Content

  • Search

View Additional Section Content

A Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of recMAGE-A3 + AS15 Antigen-Specific Cancer Immunotherapeutic as adjuvant therapy in patients with resectable MAGE-A3-positive Non-Small Cell Lung Cancer

Principal Investigator(s)
Robert A. Maxwell, M.D. (Sub-Investigator)
Peter V. Pickens, M.D. (Sub-Investigator)
Marc J. Chernoff, D.O. (Sub-Investigator)
Vishwanath Gharpure, M.D. (Sub-Investigator)
Jason A. Damsker, M.D. (Sub-Investigator)
Felice LePar, M.D. (Sub-Investigator)
Pallav Mehta, M.D. (Sub-Investigator)
Michael J. Seidman, M.D. (Sub-Investigator)
Jessica A. Berman, M.D. (Sub-Investigator)
Joseph L. Potz, M.D.

Clinical Trial Categories

  • Lung Cancer
Contact
Diane Foley, CCRP at 215-692-3213

Location

  • Abington Hematology/Oncology Associates
    Abington Health Center - Schilling
    2510 Maryland Rd, Ste 175
    Willow Grove, PA 19090-1108
    Office: 215-706-2034
    Fax: 215-706-4176

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details